Enjoying a very interesting presentation on real world data for CART in relapsed lymphoma by Dr Andrea Kuhnl. Had CART availability in England for 3 years this December. It’s transformed the pathway and offers an active treatment to patients with difficult disease.

Join us for OSU #hematology Annual Symposium this Friday, September 24 (Virtual) ccme.osu.edu/ConferenceDeta…

Excited to share our new collaborative work UKE Hamburg Nature Communications We identified the factor XII contact activation site, which enables sensitive coagulation diagnostics disq.us/t/41cafwt L B Carsten Deppermann Manuel Friese Roger Preston Evi Stavrou Thomas Renné

I confess - I used to hold VERY strong anti-vaxx beliefs. It was my body and I didn’t want others telling me what to do! But then, everything changed. I turned 5.

Case Comprehensive Cancer Center receives $12 million from NCI crainscleveland.com/lydia-coutre-b… via Crain's Cleveland Business Case Comp Cancer Ctr Cleveland Clinic

New work out / We are happy to have been contributing to provide insights on the #VITT mechanism Blood Journal UKE Hamburg DFG public | @[email protected]

The anti19 after anti19 Q Does Loncastuximab work in DLBCL Relapse After CD19 CAR-T Therapy? small N, but ~half respond and mDOR=8mons. Remember commercial CAR and Lonca have different binding sites Paolo F. Caimi Erin Reid, MD jzain58 #lymsm clinical-lymphoma-myeloma-leukemia.com/article/S2152-…

This is by no means comprehensive. But shows how we are moving away from “one size fits all” in DLBCL (does not include HGBCL-DH/TH)

My first investigator-initiated study as PI soon to open at @SeattleCCA Fred Hutchinson Cancer Center UW Medicine Aiming at keeping more liso-cel patients outside of the hospital using anakinra for CRS/ICANS prevention. clinicaltrials.gov/ct2/show/NCT04… Onward!

1. Ómicron Se transmite a una velocidad 30-50% más alta que Delta 2. La efectividad de dos dosis de AZ vs Ómicron es muy baja 3. Pfizer y Moderna siguen siendo efectivas pero pierden efectividad 4. Pfizer o Moderna + refuerzo de Pfizer o Moderna funcionan bien. Se pueden mezclar

Patients with cancer and #COVID19 had a higher risk of death if they had B cell cancer OncoAlert another reason to protect our patients with #CovidVaccine and #mask JCO Oncology Practice Tatiana Prowell, MD

ERs and ICUs across Ohio are overloaded with COVID-19 patients. The vast majority unvaccinated. This is preventable.

Pallawi Torka Kate Lurain Women In Lymphoma - [email protected] Agree with Graham Collins. There is little reason anymore not to approach well controlled HIV positive lymphoma patients as their HIV negative counterparts and include on trials of new agents: pubmed.ncbi.nlm.nih.gov/28968173/

Merry Christmas from Sen Gupta Lab! Grateful for clotting adventures w Neeves Lab Evi Stavrou Keith McCrae Samir Mitragotri Jim Morrissey Marvin Nieman Wolfgang Bergmeier Matthew D. Neal, MD Prithu Sundd Melanie Scott (@[email protected]) Wei Li Jordan Shavit Ashley Brown Alisa Wolberg Robert Campbell cecile denis 🇫🇷 Peter Lenting

"I'm so happy the paper is out for review! desk rejection rates are close to 90%!" Meanwhile in peer review:

Extremely proud today, our Nature Nano paper on a novel Nano medicine targeting activated Neuts is online!! Long journey, would not be possible without Anirban Sen Gupta, @dbohinc Matthew D. Neal, MD, Neeves Lab Marvin Nieman @Coenami, @Stevedemaat, Michelle Cruz and more. #teamwork!!

Great to see Fellow Haikoo Shah MD presenting her analysis on major cardiovascular events after CAR T. Brian Hill # CleClinCancer #ASH22 Cleveland Clinic MD

Toci shortage? Out Star PharmDs Seema Patel and Denielle Cenin have a plan for that. Siltuximab works just as well for CRS. #ASH22 #CleClinCancer Cleveland Clinic MD

Want to guess how many patients with DLBCL do not receive any treatment? Akiva Diamond presented today results of SEER - Medicare analysis. Double digits, higher in the very elderly. That is another underserved population. Case Comp Cancer Ctr #ASH22 #CleclinCancer